SIBN
SI-BONE, Inc.
NASDAQ
Healthcare
· Medical - Devices
· US
·
si-bone.com
52w Low $11.80
15.4% of range
52w High $21.89
50d MA $13.70
200d MA $16.05
P/E (TTM)
-30.0x
EV/EBITDA
-74.9x
P/B
3.2x
Debt/Equity
0.0x
ROE
-10.7%
P/FCF
-94.4x
RSI (14)
—
ATR (14)
—
Beta
0.77
50d MA
$13.70
200d MA
$16.05
Avg Volume
601.2K
About
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium …
Read more
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Show less
Recent Earnings
Date
Time
Est
Rptd
Surp
Base
Gap%
D1%
D2%
D3%
D4%
D5%
1M%
Guide ▲★
Feb 23, 2026
AMC
-0.13
-0.04
+69.2%
15.62
+5.0%
-2.1%
+1.2%
+3.9%
-0.6%
+0.5%
-17.3%
—
Nov 10, 2025
AMC
-0.16
-0.11
+31.2%
15.68
+7.0%
+16.2%
+14.8%
+10.1%
+11.1%
+14.3%
+19.8%
—
Aug 4, 2025
AMC
-0.19
-0.14
+26.3%
17.90
-3.6%
-10.6%
-8.3%
-8.8%
-12.4%
-14.0%
-9.4%
—
May 5, 2025
AMC
-0.24
-0.15
+37.5%
14.25
+11.2%
+15.4%
+22.6%
+28.6%
+29.8%
+31.8%
+29.8%
—
Feb 24, 2025
AMC
-0.15
-0.11
+24.4%
17.47
+9.4%
+5.6%
+3.9%
+1.9%
+3.7%
+0.6%
-19.6%
—
Nov 12, 2024
AMC
-0.22
-0.16
+27.3%
15.63
-13.1%
-15.9%
-20.4%
-17.3%
-20.9%
-21.2%
-12.9%
—
Aug 5, 2024
AMC
-0.26
-0.22
+15.4%
14.04
+7.8%
+1.3%
+0.6%
+1.4%
-0.4%
+0.4%
+15.8%
—
May 6, 2024
AMC
-0.29
-0.27
+6.9%
14.48
+3.6%
+8.3%
+3.6%
+7.3%
+5.9%
+3.6%
-3.0%
—
Feb 26, 2024
AMC
-0.29
-0.27
+6.9%
20.54
-9.6%
-13.5%
-15.5%
-15.5%
-16.8%
-13.4%
-23.0%
—
Nov 6, 2023
AMC
-0.33
-0.25
+24.2%
17.48
+3.0%
-2.1%
-3.3%
-7.2%
-9.9%
-8.8%
+1.8%
—
Aug 7, 2023
AMC
-0.41
-0.30
+26.8%
23.45
-1.9%
-11.2%
-13.8%
-11.9%
-8.2%
-9.2%
-5.7%
—
Show 1 more
Recent Analyst Ratings
Date
Firm
Action
Grade
Target
Base
Open
Gap%
D1%
D2%
D3%
D4%
D5%
Apr 15
Truist
Maintains
Buy → Buy
—
$14.43
$14.43
+0.0%
+0.4%
-5.3%
-2.4%
-0.8%
-4.2%
Feb 24
Truist
Maintains
Buy → Buy
—
$15.62
$16.40
+5.0%
-2.1%
+1.2%
+3.9%
-0.6%
+0.5%
Feb 24
TD Cowen
Maintains
Buy → Buy
—
$15.62
$16.40
+5.0%
-2.1%
+1.2%
+3.9%
-0.6%
+0.5%
Dec 18
Truist
Maintains
Buy → Buy
—
$19.14
$19.34
+1.0%
+5.8%
+6.5%
+8.7%
+6.5%
+6.4%
Dec 17
Canaccord Genuity
Maintains
Buy → Buy
—
$19.42
$19.50
+0.4%
-1.4%
+4.3%
+4.9%
+7.2%
+5.0%
Dec 16
Needham
Maintains
Buy → Buy
—
$18.41
$18.84
+2.3%
+5.5%
+4.0%
+10.0%
+10.7%
+13.0%
Dec 2
Morgan Stanley
Maintains
Overweight → Overweight
—
$18.87
$19.38
+2.7%
+2.9%
+1.6%
+2.0%
+4.3%
+0.7%
Oct 15
Truist
Maintains
Buy → Buy
—
$15.26
$15.27
+0.1%
-0.3%
-1.0%
-3.4%
-0.3%
+1.7%
Aug 5
Cantor Fitzgerald
Maintains
Overweight → Overweight
—
$17.90
$17.25
-3.6%
-10.6%
-8.3%
-8.8%
-12.4%
-14.0%
May 6
Truist
Maintains
Buy → Buy
—
$14.25
$15.84
+11.2%
+15.4%
+22.6%
+28.6%
+29.8%
+31.8%
May 6
Cantor Fitzgerald
Maintains
Overweight → Overweight
—
$14.25
$15.84
+11.2%
+15.4%
+22.6%
+28.6%
+29.8%
+31.8%
May 6
Needham
Maintains
Buy → Buy
—
$14.25
$15.84
+11.2%
+15.4%
+22.6%
+28.6%
+29.8%
+31.8%
Feb 25
Truist
Maintains
Buy → Buy
—
$17.47
$19.11
+9.4%
+5.6%
+3.9%
+1.9%
+3.7%
+0.6%
Feb 25
Cantor Fitzgerald
Maintains
Overweight → Overweight
—
$17.47
$19.11
+9.4%
+5.6%
+3.9%
+1.9%
+3.7%
+0.6%
Feb 25
Citizens Capital Markets
Maintains
Market Outperform → Market Outperform
—
$17.47
$19.11
+9.4%
+5.6%
+3.9%
+1.9%
+3.7%
+0.6%
Feb 25
Needham
Maintains
Buy → Buy
—
$17.47
$19.11
+9.4%
+5.6%
+3.9%
+1.9%
+3.7%
+0.6%
Jan 13
Needham
Maintains
Buy → Buy
—
$13.72
$13.82
+0.7%
+18.3%
+14.4%
+20.0%
+23.3%
+21.6%
Nov 20
Needham
Maintains
Buy → Buy
—
$12.32
$12.24
-0.6%
-1.4%
-0.2%
+1.9%
+2.7%
+5.2%
Nov 13
Truist
Maintains
Buy → Buy
—
$15.63
$13.58
-13.1%
-15.9%
-20.4%
-17.3%
-20.9%
-21.2%
Nov 13
Needham
Maintains
Buy → Buy
—
$15.63
$13.58
-13.1%
-15.9%
-20.4%
-17.3%
-20.9%
-21.2%
Oct 14
Truist
Maintains
Buy → Buy
—
$13.13
$13.13
+0.0%
-0.2%
+0.1%
+0.7%
-2.4%
+1.1%
Aug 6
Truist
Maintains
Buy → Buy
—
$14.04
$15.14
+7.8%
+1.3%
+0.6%
+1.4%
-0.4%
+0.4%
Aug 6
Needham
Maintains
Buy → Buy
—
$14.04
$15.14
+7.8%
+1.3%
+0.6%
+1.4%
-0.4%
+0.4%
Aug 6
Morgan Stanley
Maintains
Overweight → Overweight
—
$14.04
$15.14
+7.8%
+1.3%
+0.6%
+1.4%
-0.4%
+0.4%
Jul 15
Morgan Stanley
Maintains
Overweight → Overweight
—
$15.32
$15.32
+0.0%
+1.7%
+10.8%
+11.7%
+8.1%
+8.4%
May 7
Morgan Stanley
Maintains
Overweight → Overweight
—
$14.48
$15.00
+3.6%
+8.3%
+3.6%
+7.3%
+5.9%
+3.6%
May 7
JMP Securities
Maintains
Market Outperform → Market Outperform
—
$14.48
$15.00
+3.6%
+8.3%
+3.6%
+7.3%
+5.9%
+3.6%
May 7
Needham
Maintains
Buy → Buy
—
$14.48
$15.00
+3.6%
+8.3%
+3.6%
+7.3%
+5.9%
+3.6%
Apr 3
Needham
Maintains
Buy → Buy
—
$15.57
$15.61
+0.3%
+1.8%
-1.1%
-1.3%
-1.6%
+4.9%
Feb 27
Cantor Fitzgerald
Maintains
Overweight → Overweight
—
$20.54
$18.56
-9.6%
-13.5%
-15.5%
-15.5%
-16.8%
-13.4%
Feb 27
Truist
Maintains
Buy → Buy
—
$20.54
$18.56
-9.6%
-13.5%
-15.5%
-15.5%
-16.8%
-13.4%
Feb 27
Morgan Stanley
Maintains
Overweight → Overweight
—
$20.54
$18.56
-9.6%
-13.5%
-15.5%
-15.5%
-16.8%
-13.4%
Dec 22
Truist
Maintains
Buy → Buy
—
$21.09
$21.45
+1.7%
-0.3%
+1.2%
+1.4%
+1.4%
-0.5%
Dec 4
Needham
Maintains
Buy → Buy
—
$18.82
$18.50
-1.7%
-0.3%
-2.8%
-5.4%
-0.9%
+2.8%
Nov 7
Needham
Maintains
Buy → Buy
—
$17.48
$18.00
+3.0%
-2.1%
-3.3%
-7.2%
-9.9%
-8.8%
Nov 7
Morgan Stanley
Maintains
Overweight → Overweight
—
$17.48
$18.00
+3.0%
-2.1%
-3.3%
-7.2%
-9.9%
-8.8%
Nov 7
Cantor Fitzgerald
Maintains
Overweight → Overweight
—
$17.48
$18.00
+3.0%
-2.1%
-3.3%
-7.2%
-9.9%
-8.8%
Sep 26
Cantor Fitzgerald
Maintains
Overweight → Overweight
—
$21.21
$21.06
-0.7%
-2.5%
-1.2%
+0.8%
+0.1%
-0.1%
Aug 22
Cantor Fitzgerald
Maintains
Overweight → Overweight
—
$21.27
$21.40
+0.6%
+0.3%
+0.1%
+0.5%
+2.6%
+0.6%
Aug 9
Cantor Fitzgerald
Maintains
Overweight → Overweight
—
$20.83
$20.45
-1.8%
-2.9%
-0.8%
+3.4%
+2.3%
+2.7%
Aug 8
Needham
Maintains
Buy → Buy
—
$23.45
$23.00
-1.9%
-11.2%
-13.8%
-11.9%
-8.2%
-9.2%
Aug 8
Truist
Maintains
Buy → Buy
—
$23.45
$23.00
-1.9%
-11.2%
-13.8%
-11.9%
-8.2%
-9.2%
Jul 19
Truist
Maintains
Buy → Buy
—
$25.65
$26.23
+2.3%
-0.3%
-2.4%
-2.1%
-2.3%
-3.5%
Jul 12
Needham
Maintains
Buy → Buy
—
$26.38
$27.09
+2.7%
+3.7%
+1.9%
-1.0%
+0.4%
-2.8%
May 31
Morgan Stanley
Maintains
Overweight → Overweight
—
$24.90
$25.00
+0.4%
+1.1%
+1.3%
+5.9%
+7.9%
+11.1%
May 2
Cantor Fitzgerald
Maintains
Overweight → Overweight
—
$22.60
$25.00
+10.6%
+7.2%
+7.4%
+8.2%
-2.5%
-2.7%
May 2
Morgan Stanley
Maintains
Overweight → Overweight
—
$22.60
$25.00
+10.6%
+7.2%
+7.4%
+8.2%
-2.5%
-2.7%
May 2
Canaccord Genuity
Maintains
Buy → Buy
—
$22.60
$25.00
+10.6%
+7.2%
+7.4%
+8.2%
-2.5%
-2.7%
May 2
Needham
Maintains
Buy → Buy
—
$22.60
$25.00
+10.6%
+7.2%
+7.4%
+8.2%
-2.5%
-2.7%
Feb 28
Canaccord Genuity
Maintains
Buy → Buy
—
$16.94
$19.78
+16.8%
+16.7%
+18.1%
+18.1%
+20.1%
+20.9%
Show 40 more
Data updated apr 27, 2026 1:13am
· Source: massive.com